peer-reviewed journals, qualifying minimally as phase 2 clinical sensitivity (100% median per participant) with a false alarm rate
validation trials, in accordance with standards for testing and at 0.04 per h (median per patient) for nocturnal motor seizures
2P.MeritamLarsenandSÃ¡ndorBeniczky Epilepsy&Behavior148(2023)109486
in children, using a multimodal device including accelerometry alarmrate(0.53perh),themajorityofpatientsdidnotexperience
and heart rate detection (NightWatch), reducing caregiver stress anyfalsealarmsatall.
butnotshowingasignificanteffectonthequalityoflife(QoL)or Even though most studies published on seizure detection